All lobbying filings
S-3 GROUP
S-3 GROUP filed a Q2 report for WALGREEN COMPANY on July 17, 2026, reporting $50,000 in lobbying income.
Lobbying for WALGREEN COMPANY · Pharmacy-led, health and wellbeing retail company
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 17, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbyists on this filing
7
-
MALLOY MCDANIELPreviously held: Policy Advisor, Senate Minority Leader Mitch McConnell; Whip Liaison, Senate Majority Whip Mitch McConnell; Floor Assistant, Senate Majority Leader Trent Lott; Cloakroom Assistant, Office of the Republican Secretary
-
ASHLEY DAVISPreviously held: Special Assistant to the Homeland Security Director, Executive Office of the President; Deputy Director of Management and Administration, Executive Office of the President
-
KRISTI REMINGTONPreviously held: Deputy Assistant Attorney General, US Department of Justice; Senior Counsel, House Government Reform Committee
-
SHIMON STEINPreviously held: Senior Policy Advisory, House Majority Leader Eric Cantor, Program Manager, US Department of Justice, Legislative Correspondent, Senator John Ashcroft; Paid Intern, Representative Robert Aderholt
-
CHRISTOPHER BUKIPreviously held: Staff Assistant/Legislative Correspondent, Representative John Culberson; Legislative Assistant/Senior Legislative Assistant, Representative Bill Shuster; Legislative Director/Deputy Chief of Staff, Representative David McKinley
-
MARTIN REISERPreviously held: Policy Director, Republican Whip Steve Scalise, professional staff House Ways and Means Committee, Chief of Staff, Rep. Dan Miller, Budget Associate, House Budget Committee
-
CHRIS ARNESON New on this filingPreviously held: Economic Policy Director, Chief Budget and Economic Advisor, Senior Tax Policy Advisor, Tax Policy Advisor, Research Associate, Research Assistant, Associate Investigator, Senate Finance Committee
Government bodies contacted
2
Lobbying activity
3
Issues related to the provider status of pharmacists under Medicare Part B
Issues related to pharmacy, pharmacist provider status, pharmacy benefit managers, Medicare reimbursement, and pharmaceutical supply chain transparency
Issues related to preventing organized retail crime, including the Combatting Organized Retail Crime Act: (H.R. 2853/S.1404)